Saqib Islam is Chief Executive Officer of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 1.06 Million shares of SWTX, which is worth approximately $35.2 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 49,000 shares (Common Stock) at a price of $41.09 per share, resulting in proceeds of $2,013,410. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.06M
4.41% 3M change
17.49% 12M change
Total Value Held $35.2 Million

Saqib Islam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Open market or private sale
$2,013,410 $41.09 p/Share
49,000 Reduced 4.41%
1,063,368 Common Stock
Jun 03 2024
SELL
Open market or private sale
$2,002,629 $40.87 p/Share
49,000 Reduced 4.22%
1,112,368 Common Stock
Jan 08 2024
SELL
Payment of exercise price or tax liability
$743,553 $41.53 p/Share
17,904 Reduced 6.53%
256,264 Common Stock
Jan 05 2024
SELL
Payment of exercise price or tax liability
$489,114 $37.96 p/Share
12,885 Reduced 4.49%
274,168 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
88,000 Added 23.46%
287,053 Common Stock
Nov 30 2023
BUY
Grant, award, or other acquisition
-
199,053 Added 50.0%
199,053 Common Stock
Jan 07 2023
SELL
Payment of exercise price or tax liability
$108,201 $26.41 p/Share
4,097 Reduced 0.45%
905,104 Common Stock
Jan 06 2023
SELL
Payment of exercise price or tax liability
$231,168 $27.52 p/Share
8,400 Reduced 0.92%
909,201 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
84,175 Added 8.4%
917,601 Common Stock
Jan 07 2022
SELL
Payment of exercise price or tax liability
$330,362 $56.06 p/Share
5,893 Reduced 0.69%
851,695 Common Stock
Jan 06 2022
BUY
Grant, award, or other acquisition
-
78,370 Added 8.37%
857,588 Common Stock
Oct 20 2021
SELL
Open market or private sale
$591,570 $58.67 p/Share
10,083 Reduced 1.28%
779,218 Common Stock
Oct 19 2021
SELL
Open market or private sale
$827,868 $58.81 p/Share
14,077 Reduced 1.8%
769,135 Common Stock
Oct 18 2021
SELL
Open market or private sale
$2,246,341 $58.59 p/Share
38,340 Reduced 4.67%
783,212 Common Stock
Jul 20 2021
SELL
Open market or private sale
$1,442,673 $77.68 p/Share
18,572 Reduced 2.21%
821,552 Common Stock
Jul 19 2021
SELL
Open market or private sale
$3,342,481 $76.09 p/Share
43,928 Reduced 4.97%
840,124 Common Stock
Apr 20 2021
SELL
Open market or private sale
$1,598,339 $66.39 p/Share
24,075 Reduced 2.65%
884,052 Common Stock
Apr 19 2021
SELL
Open market or private sale
$2,652,862 $69.04 p/Share
38,425 Reduced 4.06%
908,127 Common Stock
Jan 20 2021
SELL
Open market or private sale
$173,171 $78.75 p/Share
2,199 Reduced 0.18%
1,222,997 Common Stock
Jan 19 2021
SELL
Open market or private sale
$4,736,041 $78.54 p/Share
60,301 Reduced 4.69%
1,225,196 Common Stock
Jan 07 2021
BUY
Grant, award, or other acquisition
-
37,500 Added 2.83%
1,285,497 Common Stock

Also insider at

SBTX
Silverback Therapeutics, Inc. Healthcare
PASG
Passage BIO, Inc. Healthcare
SI

Saqib Islam

Chief Executive Officer
Stamford, CT

Track Institutional and Insider Activities on SWTX

Follow SpringWorks Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX